Mr. Ismail Ibrahim | Neuroscience | Editorial Board Member

Mr. Ismail Ibrahim is an emerging multidisciplinary researcher whose work spans neurobiology, physiotherapy, public health, clinical neuroscience, oncology, infectious diseases, and evidence-based rehabilitation sciences. His research portfolio includes numerous peer-reviewed publications, systematic reviews, meta-analyses, case reports, and multinational cross-sectional studies addressing critical clinical and epidemiological problems. He has contributed to major studies on post-COVID-19 health challenges, public responses to infectious disease outbreaks, vaccine awareness, and antimicrobial resistance, alongside impactful research on glioblastoma progression, neurodegenerative disorders, immuno-oncology, and advanced diagnostic techniques. His scientific output also extends to innovative investigations on stem-cell-based therapies, neuromodulation interventions such as tDCS and TMS, robotic-assisted rehabilitation technologies, cardiovascular robotic surgery, musculoskeletal rehabilitation, sports performance, and pediatric and adult neurological conditions. He has produced extensive work analyzing cancer outcomes using large clinical databases, explored radiological and thermographic diagnostic tools, and conducted comprehensive reviews on endocrine disorders, metabolic diseases, and neuroimmunological interactions. His submissions further highlight contributions to AI integration in healthcare, high-fidelity surgical simulation, endocrinology, neurorehabilitation, physiotherapy optimization, and global public health threats including Nipah virus and monkeypox. Through his broad research involvement across diverse medical and scientific disciplines, he demonstrates a strong commitment to advancing clinical evidence, improving patient outcomes, and informing healthcare innovation through rigorous, multidisciplinary inquiry.